News
- Author:
- Maiya Focht
Publish date: January 31, 2023
A new study finds that 25% of health care workers polled were willing to quit because of violence while at work.
News
- Author:
- Maiya Focht
Publish date: August 16, 2022
Dermatologists reviewed five treatments that represent some of the most frequently discussed hair-growth trends on social media: rosemary, onion ju...
News
- Author:
- Maiya Focht
Publish date: August 16, 2022
Although these ingredients are exceedingly safe with temporary, localized use, high concentrations and chronic use of calamine lotion can be irrita...
News
- Author:
- Maiya Focht
Publish date: August 10, 2022
Intradermal administration will allow providers to get five doses out of a one-dose vial.
News
- Author:
- Maiya Focht
Publish date: August 9, 2022
Dr. Roberts was among the first physicians in the world to be board certified in EM and coauthored the foundational EM text.
News
- Author:
- Maiya Focht
Publish date: August 1, 2022
In clinical trials, topical roflumilast was effective in treating psoriasis in intertriginous areas, including the buttocks, underarms, and beneath...
News
- Author:
- Maiya Focht
Publish date: July 28, 2022
Children with lupus-related kidney damage can now receive the B cell–reducing therapy that adults with lupus nephritis have been able to get for th...
News
- Author:
- Maiya Focht
Publish date: July 28, 2022
The same genes that influence Alzheimer’s disease were found in a host of gut disorders, according to a new study out of Australia.
News
- Author:
- Maiya Focht
Publish date: July 19, 2022
Approval was based on the results of two phase 3 trials in 674 patients with nonsegmental vitiligo aged 12 years or older.
News
- Author:
- Maiya Focht
Publish date: July 12, 2022
In the phase 4 trial, co-administration of pegloticase and methotrexate reduced the formation of new anti-PEG antibodies.
News
- Author:
- Maiya Focht
Publish date: July 7, 2022
These types of vaccines work by creating a larger immune response than a standard vaccine dose.
News
- Author:
- Maiya Focht
Publish date: July 5, 2022
Over time, even with improvements across the board in care, women and people of color wait longer for treatment of myocardial infarction than their...
News
- Author:
- Maiya Focht
Publish date: June 30, 2022
Zelnorm, a short-term IBS-C treatment, has been removed from the market. The drug manufacturer cited “business concerns.”
News
- Author:
- Maiya Focht
Publish date: June 29, 2022
When using the backup power source, clinicians should make sure to have alternative routes for breathing support on hand.
News
- Author:
- Maiya Focht
Publish date: June 24, 2022
The risk is especially high because Volara is designed to be used in outpatient settings.
